MODERATOR(S)
Lachlan McDowell, PhD, MBBS, FRANZCR - Princess Alexandra Hospital
Ryan Morse, MD - University of Kansas Medical Center
session DESCRIPTION
Quick Pitch sessions provide opportunities for presenters to summarize outcomes while highlighting key takeaways from their research in a fast-paced format to present concise takeaways.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
09:15am - 09:20am ETSpeaker: Lachlan McDowell, PhD, MBBS, FRANZCR - Princess Alexandra Hospital, Woolloongabba
-
09:15am - 10:15am ETSpeaker: Lachlan McDowell, PhD, MBBS, FRANZCR - Princess Alexandra Hospital, Woolloongabba
-
09:15am - 10:15am ETSpeaker: Ryan Morse, MD - University of Kansas Medical Center, Kansas City
-
09:20am - 09:25am ET
Hypo-Slow Radiotherapy Combined with Capecitabine in Very Elderly Patients (=78 Years) with Locally Advanced Head and Neck Cancer: A Prospective Exploratory Study
Speaker: Shichuan Zhang, MD, PhD - Sichuan Cancer Hospital and Institute, ??? -
09:25am - 09:30am ET
Split-Course Hypofractionated Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Carcinoma: A Single-Center Prospective Phase II study
Speaker: Jia-Xuan Yang, MS - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing -
09:30am - 09:35am ET
Somatic Genetic Variants as Predictors for Radiation-Induced Short and Long-Term Toxicity in Head and Neck Cancers
Speaker: Austin Thompson, MD - University of Maryland Medical Center, Baltimore -
09:35am - 09:40am ET
Genetic Signatures Predicting Toxicity and Overall Survival in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients in RTOG 0522 Treated with Radiation and Cisplatin
Speaker: Joanne Weidhaas, MD, PhD - UCLA Radiation Oncology, Los Angeles -
09:40am - 09:45am ET
Stereotactic Ablative Radiotherapy (SABR) for Early Stage Glottic Cancer: A Multi-Institutional Pooled Analysis of Long-Term Efficacy, Toxicity and Voice Outcomes
Speaker: Sympascho Young, MD, BS - UT Southwestern Medical Center, Dallas -
09:45am - 09:50am ET
Prospective Evaluation of Daily Online Adaptive Radiotherapy with 1mm PTV Margins in High Risk HPV Negative Head and Neck Cancer
Speaker: Harjot Bajwa, MD - American Oncology Institute, Hyderabad -
09:50am - 10:10am ETSpeaker: Ryan Morse, MD - University of Kansas Medical Center, Kansas City
-
10:10am - 10:15am ETSpeaker: Lachlan McDowell, PhD, MBBS, FRANZCR - Princess Alexandra Hospital, Woolloongabba